Public Profile

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a prominent player in the biopharmaceutical industry, is headquartered in Grand Island, New York, with significant operations across the United States and Europe. Founded in 2012, the company has rapidly established itself as a leader in biomanufacturing, specialising in the development and production of biologics, including monoclonal antibodies and recombinant proteins. With a commitment to innovation, FUJIFILM Diosynth offers unique services such as cell line development, process development, and large-scale manufacturing, utilising cutting-edge technologies to ensure high-quality outputs. The company has achieved notable milestones, including partnerships with major pharmaceutical firms, solidifying its market position as a trusted contract development and manufacturing organisation (CDMO). Through its dedication to excellence, FUJIFILM Diosynth continues to advance the biopharmaceutical landscape, supporting the delivery of life-saving therapies worldwide.

DitchCarbon Score

How does FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s score of 41 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s reported carbon emissions

FUJIFILM Diosynth Biotechnologies U.S.A., Inc., headquartered in Great Britain, currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. In the absence of emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of publicly available information may suggest that they are still in the process of developing their climate strategy or have not yet formalised their commitments to carbon reduction. As the biotechnology industry increasingly prioritises sustainability, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. may be expected to align with industry standards and practices in addressing climate change and reducing carbon emissions in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for FUJIFILM Diosynth Biotechnologies U.S.A., Inc. is in GB, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

FUJIFILM Diosynth Biotechnologies U.S.A., Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Avid Bioservices

US
Furniture; other manufactured goods n.e.c. (36)
Updated 2 days ago

Thermo Fisher Scientific

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Charles River Laboratories

US
Research and development services (73)
Updated 2 days ago

NATIONAL RESILIENCE INC

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Vetter Pharma

DE
Medical, precision and optical instruments, watches and clocks (33)
Updated about 16 hours ago

Berkshire Sterile Manufacturing, LLC

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers